Skip to main content
AAN.com
Articles
July 25, 2005

Epidemiology of restless legs syndrome in French adults
A nationwide survey: The INSTANT Study

Abstract

Objective: To evaluate the prevalence, characteristics, and treatment of restless legs syndrome (RLS) in France.
Methods: In this population-based survey, face-to-face home interviews were conducted among a random sample of 10,263 French adults. A French translation of the four features defined by the International RLS Study Group in 1995 was used to assess the prevalence of symptoms consistent with a diagnosis of RLS. Data on severity of symptoms and their management were also collected.
Results: The 12-month prevalence of RLS symptoms in the French adult population was estimated to be 8.5% (95% CI 8.0%, 9.0%), with a higher prevalence (p < 0.001) observed in women (10.8%) than in men (5.8%). Prevalence increases with age until 64 years and decreases thereafter in both sexes. Half of the identified subjects reported symptoms once a week at least. Symptoms were more severe in subjects reporting symptoms once a week at least compared to subjects with less frequent symptoms. In this group, half of the subjects reported a family history, the age at onset was earlier, and severity of symptoms higher. RLS had been previously diagnosed in only 5.3% of the subjects who reported previous medical diagnosis, and recommended RLS drug treatment was received by 3.4% of the 28.7% currently treated subjects.
Conclusions: Restless legs syndrome (RLS) occurred in 10% of women and 5% of men. RLS prevalence decreases after the age of 64. RLS is often underdiagnosed and few subjects receive recommended RLS drug treatment.

Get full access to this article

View all available purchase options and get full access to this article.

Supplementary Material

File (e1.doc)

References

1.
The International Restless Legs Syndrome Study Group, Walters SA. Toward a better definition of the restless legs syndrome. Mov Disord 1995;10:634–642.
2.
Allen RP, Picchietti D, Hening WA, Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4:101–119.
3.
Ekbom KA. Restless legs. Acta Med Scand 1945;suppl 158.
4.
Tan EK, Seah A, See SJ, Lim E, Wong MC. Restless legs syndrome in an Asian population: a study in Singapore. Mov Disord 2001;16:577–578.
5.
Sevim S, Dogu O, Camdeviren H, Unexpectedly low prevalence and unusual characteristics of RLS in Mersin, Turkey. Neurology 2003;61:1562–1569.
6.
Ulfberg J, Nystrom B, Carter N, Edling C. Restless legs syndrome among working-aged women. Eur Neurol 2001;46:17–19.
7.
Ulfberg J, Nystrom B, Carter N, Edling C. Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms. Mov Disord 2001;16:1159–1163.
8.
Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs syndrome in adults. Arch Internal Med 2000;160:2137–2141.
9.
Winkelmann J, Wetter TC, Collado-Seidel V, Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients. Sleep 2000;23:597–602.
10.
Lavigne GJ, Montplaisir JY. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 1994;17:739–743.
11.
Deroo M Dussaix AM. Pratique et analyse des enquêtes par sondage. Paris: PUF Paris, 1980.
12.
Recensement de la population. Available at: www.recensement.insee.fr
13.
The International Restless Legs Syndrome Study Group. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003;4:121–132.
14.
Odin P, Mrowka M, Shing M. Restless legs syndrome. Eur J Neurol 2002;9(suppl 3):59–67.
15.
Hening W, Walters AS, Allen RP, Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS Epidemiology, Symptoms, and Treatment) primary care study. Sleep Med 2004;5:237–246.
16.
Berger K, Luedemann J, Trenkwalder C, Ulrich J, Kessler C. Sex and the risk of restless sex syndrome in the general population. Arch Intern Med 2004;164:196–202.
17.
Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and morbidity in Augsburg elderly. Neurology 2000;54:1064–1068.
18.
National Sleep Foundation. 2001 Omnibus sleep in America poll. Available at: http://www.sleepfoundation.org/publications/2001poll.cfm
19.
Allen RP, La Buda MC, Becker P, Earley CJ. Family history study of the restless legs syndrome. Sleep Med 2002;3 suppl:S3–7.
20.
Zucconi M, Ferini-Strambi L. Epidemiology and clinical findings of restless legs syndrome. Sleep Med 2004;5:293–299.
21.
Nichols DA, Allen RP, Grauke JH, Restless legs syndrome symptoms in primary care: a prevalence study. Arch Intern Med 2003;163:2323–2329.
22.
Hornyak M, Trenkwalder C. Restless legs syndrome and periodic limb movement disorder in the elderly. J Psychosom Res 2004;56:543–548.
23.
Winkelmann J, Muller-Myhsok B, Wittchen HU, Complex segregation analysis of restless legs syndrome provides evidence for an autosomal dominant mode of inheritance in early age at onset families. Ann Neurol 2002;52:297–302.
24.
Desautels A, Turecki G, Montplaisir J, Evidence for a genetic association between monoamine oxidase A and restless legs syndrome. Neurology 2002;59:215–219.
25.
Bonati MT, Ferini-Strambi L, Aridon P, Oldani A, Zucconi M, Casari G. Autosomal dominant restless legs syndrome maps on chromosome 14q. Brain 2003;126:1485–1492.
26.
Brooks DG. The first genetic locus mapped for RLS is unlikely to be the last. Article reviewed: “Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q. ”Sleep Med 2002;3:285–286.
27.
Ondo WG, Vuong KD, Wang Q. Restless legs syndrome in monozygotic twins: clinical correlates. Neurology 2000;55:1404–1406.
28.
Chen S, Ondo WG, Rao S, Li L, Chen Q, Wang Q. Genome-wide linkage scan identifies a novel susceptibility locus for restless legs syndrome on chromosome 9p. Am J Hum Genet 2004;74:876–885.
29.
Allen RP, Kushida CA, Atkinson MJ, RLS QoL Consortium. Factor analysis of the International Restless Legs Syndrome Study Group's scale for restless legs severity.Sleep Med 2003;4:133–135.
30.
Van de Vijver DA, Walley T, Petri H. Epidemiology of restless legs syndrome as diagnosed in UK primary care. Sleep Med 2004;5:435–440.
31.
Earley CJ. Restless legs syndrome. N Engl J Med 2003;348:2103–2109.
32.
Fowkes FG, Evans CJ, Lee AJ. Prevalence and risk factors of chronic venous insufficiency. Angiology 2001;52 suppl 1: S5–15.

Information & Authors

Information

Published In

Neurology®
Volume 65Number 2July 26, 2005
Pages: 239-246
PubMed: 16043793

Publication History

Published online: July 25, 2005
Published in print: July 26, 2005

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

F. Tison, MD
From Hôpital Haut Levêque (Dr. Tison), Pessac; Laboratoires GlaxoSmithKline (Drs. Crochard and El Hasnaoui), Marly le Roi; Hôtel de Dieu de Paris (Dr. Léger), Paris; CEMKA-EVAL (Dr. Bouée), Bourg la Reine; and Hôpital Européen Georges Pompidou (Dr. Lainey), Paris, France.
A. Crochard, PhD
From Hôpital Haut Levêque (Dr. Tison), Pessac; Laboratoires GlaxoSmithKline (Drs. Crochard and El Hasnaoui), Marly le Roi; Hôtel de Dieu de Paris (Dr. Léger), Paris; CEMKA-EVAL (Dr. Bouée), Bourg la Reine; and Hôpital Européen Georges Pompidou (Dr. Lainey), Paris, France.
D. Léger, MD
From Hôpital Haut Levêque (Dr. Tison), Pessac; Laboratoires GlaxoSmithKline (Drs. Crochard and El Hasnaoui), Marly le Roi; Hôtel de Dieu de Paris (Dr. Léger), Paris; CEMKA-EVAL (Dr. Bouée), Bourg la Reine; and Hôpital Européen Georges Pompidou (Dr. Lainey), Paris, France.
S. Bouée, MD
From Hôpital Haut Levêque (Dr. Tison), Pessac; Laboratoires GlaxoSmithKline (Drs. Crochard and El Hasnaoui), Marly le Roi; Hôtel de Dieu de Paris (Dr. Léger), Paris; CEMKA-EVAL (Dr. Bouée), Bourg la Reine; and Hôpital Européen Georges Pompidou (Dr. Lainey), Paris, France.
E. Lainey, MD
From Hôpital Haut Levêque (Dr. Tison), Pessac; Laboratoires GlaxoSmithKline (Drs. Crochard and El Hasnaoui), Marly le Roi; Hôtel de Dieu de Paris (Dr. Léger), Paris; CEMKA-EVAL (Dr. Bouée), Bourg la Reine; and Hôpital Européen Georges Pompidou (Dr. Lainey), Paris, France.
A. El Hasnaoui, MD, PhD
From Hôpital Haut Levêque (Dr. Tison), Pessac; Laboratoires GlaxoSmithKline (Drs. Crochard and El Hasnaoui), Marly le Roi; Hôtel de Dieu de Paris (Dr. Léger), Paris; CEMKA-EVAL (Dr. Bouée), Bourg la Reine; and Hôpital Européen Georges Pompidou (Dr. Lainey), Paris, France.

Notes

Address correspondence and reprint requests to Dr. Anne Crochard, Laboratoire GlaxoSmithKline, 100 route de Versailles, 78163 Marly-Le-Roi Cedex, France; e-mail: [email protected]

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Spectrum of Restless Leg Syndrome from a Tertiary Care Hospital in Eastern India, Bengal Physician Journal, 11, 2, (73-75), (2024).https://doi.org/10.5005/jp-journals-10070-8051
    Crossref
  2. Prevalence and clinical correlates of restless legs syndrome in psychiatric patients: A cross-sectional study from North India, Indian Journal of Psychiatry, 66, 1, (58-66), (2024).https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_223_23
    Crossref
  3. Sleep related movement disorders in the elderly: a review of recent literature, Frontiers in Sleep, 3, (2024).https://doi.org/10.3389/frsle.2024.1356644
    Crossref
  4. Dopamine Agonists in the Treatment of Restless Legs Syndrome: Too Much of a Good Thing?, Journal of Sleep Medicine, 21, 1, (1-5), (2024).https://doi.org/10.13078/jsm.230030
    Crossref
  5. Aide thérapeutique à l’amélioration du sommeil, Soins Psychiatrie, 45, 352, (28-31), (2024).https://doi.org/10.1016/j.spsy.2024.03.010
    Crossref
  6. Coexistence of periodic limb movements during sleep with restless legs syndrome and its association with hypertension in Japanese patients, Sleep Medicine, 115, (187-192), (2024).https://doi.org/10.1016/j.sleep.2024.02.024
    Crossref
  7. Restless Legs Syndrome and Nocturnal Movement Disorders, Reference Module in Neuroscience and Biobehavioral Psychology, (2024).https://doi.org/10.1016/B978-0-323-95702-1.00142-1
    Crossref
  8. Restless Legs Syndrome in Parkinson’s Disease, Journal of Personalized Medicine, 13, 6, (915), (2023).https://doi.org/10.3390/jpm13060915
    Crossref
  9. Restless Leg Syndrome in Hospitalized Psychiatric Patients in Mashhad, Sleep Medicine Research, 14, 3, (161-167), (2023).https://doi.org/10.17241/smr.2022.01354
    Crossref
  10. Worldwide estimation of restless legs syndrome: a systematic review and meta‐analysis of prevalence in the general adult population, Journal of Sleep Research, 32, 3, (2023).https://doi.org/10.1111/jsr.13783
    Crossref
  11. See more
Loading...

View Options

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share